Acute toxicity in 14 patients with locally advanced head and neck squamous cell carcinoma treated with concurrent cetuximab and radiotherapy;Tossicità acuta in 14 pazienti affetti da carcinoma squamoso localmente avanzato del distretto testa-collo trattati con radioterapia e cetuximab concomitante

Radiologia Medica

Volumn 117, Issue 1, 2012, Pages 125-132

  Valeriani, M ^a   Muni, R ^a   Osti, M F ^a   Sanctis, V ^a   Minniti, G ^a   Ardito, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cetuximab; Head and neck tumours; Radiotherapy; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; FEMALE; HEAD AND NECK TUMOR; HUMAN; ITALY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROSPECTIVE STUDY; RADIATION DERMATITIS; RADIATION RESPONSE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; ITALY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIODERMATITIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84857657924     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-011-0716-3     Document Type: Article

References (12)

1. J.P. Pignon J. Bourhis C. Domenge L. Designè 2000 Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer Lancet 355 949 955 10768432 1:STN:280:DC%2BD3c3ivV2iuw%3D%3D (Pubitemid 30148259)
2. E.E. Cohen M.W. Lingen E.E. Vokes 2004 The expanding role of systemic therapy in head and neck cancer J Clin Oncol 22 1743 1752 15117998 10.1200/JCO.2004.06.147 (Pubitemid 41079815)
3. A.S. Garden J.A. Asper W.H. Morrison, et al. 2004 Is concurrent chemoradiation the treatment of choice for all patients with stage III or IV head and neck carcinoma? Cancer 100 1171 1178 15022283 10.1002/cncr.20069 (Pubitemid 38325944)
4. V. Krstevska 2009 Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma J Buon 14 361 373 19810125 1:STN:280: DC%2BD1MnnsVOhug%3D%3D
5. J.A. Bonner P.M. Harari J. Giralt, et al. 2006 Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Eng J Med 354 567 578 10.1056/NEJMoa053422 1:CAS:528:DC%2BD28Xhtleksbs%3D (Pubitemid 43209104)
6. J.A. Bonner P.M. Harari J. Giralt, et al. 2010 Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 21 28 19897418 10.1016/S1470-2045(09)70311-0 1:CAS:528:DC%2BC3cXjslKktA%3D%3D
7. A.M. Chen L.M. Chen A. Vaughan, et al. 2011 Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome Int J Radiat Oncol Biol Phys 79 414 419 20399030 10.1016/j.ijrobp.2009. 10.050
8. T. Rugg M. I. Saunders S. Dische 1990 Smoking and mucosal reactions to radiotherapy Br J Radiol 63 554 556 2390690 10.1259/0007-1285-63-751-554 1:STN:280:DyaK3czmtVWrug%3D%3D (Pubitemid 20218901)
9. D.I. Pryor S.V. Porceddu B.H. Burmeister, et al. 2009 Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer Radiother Oncol 90 172 176 18976827 10.1016/j.radonc.2008.09.018 1:CAS:528: DC%2BD1MXhvFGkt7s%3D
10. Koutcher LD, Wolden S, Lee N (2009) Severe radiation dermatitis in patients with locally advanced head and neck cancer treated with concurrent radiation and cetuximab. Am J Clin Oncol [Epub ahead of print]
11. C. Giro B. Berger E. Bolke, et al. 2009 High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes Radiother Oncol 90 166 171 18977050 10.1016/j.radonc.2008.09.007 1:CAS:528:DC%2BD1MXhvFGkt7o%3D
12. A. Azad 2009 Severe cutaneous toxicity following treatment with radiotheraphy and cetuximab: a case report Cases Journal 2 25 19128507 10.1186/1757-1626-2-25